GMAB

GMAB

USD

Genmab A/S ADS

$28.975+0.435 (1.524%)

リアルタイム価格

Healthcare
バイオテクノロジー
デンマーク

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$28.540

高値

$29.390

安値

$28.510

出来高

2.92M

企業ファンダメンタルズ

時価総額

17.8B

業種

バイオテクノロジー

Denmark

取引統計

平均出来高

2.00M

取引所

NMS

通貨

USD

52週レンジ

安値 $17.235現在値 $28.975高値 $33.65

関連ニュース

BusinessWire

Genmab to Showcase Latest Blood Cancer Treatment Advancements at 2025 American Society of Hematology (ASH) Annual Meeting

More than 20 abstracts, including seven oral presentations, highlight advancements from the epcoritamab development program supporting the expanded clinical profile and potential of epcoritamab for a broader range of

もっと見る
Genmab to Showcase Latest Blood Cancer Treatment Advancements at 2025 American Society of Hematology (ASH) Annual Meeting
Analyst Upgrades

HC Wainwright & Co. Reiterates Buy on Genmab, Maintains $40 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Genmab with a Buy and maintains $40 price target.

もっと見る
HC Wainwright & Co. Reiterates Buy on Genmab, Maintains $40 Price Target
GlobeNewswire

Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2025

Company Announcement Net sales of DARZALEX® in the third quarter of 2025 totaled USD 3,672 millionGenmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech,

もっと見る
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2025